• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
LeadershipPfizer

Pfizer CEO slams Harvard, MIT, and Penn leaders for their ‘despicable’ testimony about antisemitism and genocide

By
Simone Foxman
Simone Foxman
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Simone Foxman
Simone Foxman
and
Bloomberg
Bloomberg
Down Arrow Button Icon
December 6, 2023, 5:17 PM ET
Pfizer CEO Dr. Albert Bourla.
Pfizer CEO Dr. Albert Bourla.Drew Angerer/Getty Images

Pfizer chief executive Albert Bourla slammed testimonies by the heads of three top American universities for failing to “condemn racist, antisemitic, hate rhetoric” while speaking in front of members of congress Tuesday.

Testimony by the presidents of Harvard University, the University of Pennsylvania and the Massachusetts Institute of Technology “was one of the most despicable moments in the history of U.S. Academia,” Bourla said in a post on X, formerly known as Twitter.

Harvard’s Claudine Gay, Penn’s Liz Magill and MIT President Sally Kornbluth testified about efforts to combat antisemitism on their campuses in the wake of the Oct. 7 attack on Israel by Hamas, which is designated a terrorist group by the US and European Union. The presidents faced criticism by lawmakers, students and alumni, including financiers Cliff Asness and Bill Ackman, after refusing to say that calling for the genocide of Jews was against their schools’ policies. Magill and Gay said it depended on the context.

Bourla, who in 2020 struck an agreement with Israeli prime minister Benjamin Netanyahu to use Israel as a test case for Pfizer’s Covid-19 vaccine, said his grandparents, aunt and uncle, perished at Auschwitz. 

“I was wondering if their deaths would have provided enough ‘context’ to these presidents to condemn the Nazis’ antisemitic propaganda,” he added, alongside a picture of his aunt, Graciela. He said she was killed in the death camp at the age of 17. “Unfortunately, no pictures of my grandparents and uncle survived. I still wonder what they looked like,” he added.

Coins2Day Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Coins2Day Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Authors
By Simone Foxman
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.